337-1519 - ITC Investigation

Certain Melanoma Predictive and Prognostic Tests and Components Thereof; Inv. No. 337-TA-1519

Overview

Status: Active
Phase: Violation
Docket: 3921
Type: Sec 337
Start Date: Aug 25, 2026
End Date: -
Init Doc Received Date: Aug 25, 2026

Parties on record (5)

PartyTypeLaw firm
Castle Biosciences, Inc.ComplainantArnall Golden Gregory LLP
Qiagen GmbHRespondentMintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
QIAGEN LLCRespondentMintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
SkylineDx Holding B.V.RespondentWilmer Cutler Pickering Hale and Dorr LLP
SkylineDx USA, Inc.RespondentWilmer Cutler Pickering Hale and Dorr LLP
Counsel of record, emails and dispositions for all 5 parties

5 of 5 parties shown.

Federal Register Notices (1)

DateTypeTitleLinks
Aug 27, 2026InstitutionCertain Melanoma Predictive and Prognostic Tests and Components Thereof; Notice of Institution of Investigation

Filing timeline (20)

DateTypeDocuments
Sep 22, 2026Answer to Complaint1 document
Sep 14, 2026PO Subscription1 document
Sep 10, 2026Response/Submission to ALJ Order1 document
Sep 10, 2026PO Subscription1 document
Sep 10, 2026PO Subscription1 document
Sep 9, 2026Voting Sheet1 document
Sep 9, 2026Correspondence - USITC1 document
Aug 31, 2026Request for Confidential Materials1 document
Aug 31, 2026PO Subscription1 document
Aug 28, 2026Notice of Appearance1 document
Aug 28, 2026Request for Confidential Materials1 document
Aug 28, 2026PO Subscription1 document
Aug 27, 2026Notice1 document
Aug 27, 2026Order2 documents
Aug 27, 2026Order2 documents
Aug 27, 2026Order2 documents
Aug 27, 2026Voting Sheet1 document
Aug 25, 2026Notice1 document
Aug 25, 2026Order, Commission1 document
Aug 25, 2026Notice1 document
All 20 filings, with attachments and filing parties

20 of 20 filings shown.

Complete case file

Everything on record for 337-1519, in one email:

  • 0 asserted patents
  • 5 parties, with law firms, counsel of record, emails and dispositions
  • 20 filings, with dates, types, filing parties and attachments
Sent to your work email.